Quant Momentum Fund
The scheme seeks to achieve long-term capital appreciation for its investors. This objective will be pursued by strategically investing in a diversified portfolio of equity and equity-related instruments. The selection of these instruments will be based on a quantitative model meticulously designed to identify potential investment opportunities that exhibit the potential for significant capital appreciation over the specified investment horizon. There is no assurance that the investment objective of the Scheme will be realized.
Growthvine rating: 3/5 — ranked #72 of 186 in category.
Fund basics
| Category | Equity: Thematic |
|---|
| NAV | ₹14.33 (as of 2026-10-22) |
|---|
| AUM | ₹1,269 Cr |
|---|
| Expense ratio | 1.86% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Ayusha Kumbhat |
|---|
| Exit load | 1% for redemption within 15 days |
|---|
Performance & risk
| Standard deviation | 0.00% |
|---|
| Max drawdown | −23.08% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Over 5 years, captured 75.6% of NIFTY Alpha 50's upside and 58.3% of its downside.
Market cap allocation
| Large cap | 65.3% |
|---|
| Mid cap | 24.6% |
|---|
| Small cap | 10.2% |
|---|
Concentration
| Top 5 holdings | 45.0% |
|---|
| Top 10 holdings | 68.3% |
|---|
| Total holdings | 17 |
|---|
Top holdings
- TREPS 01-Oct-2026 DEPO 10 — 18.5%
- INDUS TOWERS LIMITED — 9.4%
- Aurobindo Pharma Ltd. — 9.3%
- Adani Enterprises Ltd. — 9.1%
- Piramal Finance Limited — 8.8%
- Adani Green Energy Limited — 8.3%
- Reliance Industries Ltd — 6.7%
- Bharat Heavy Electricals Ltd. — 4.9%
- Hexaware Technologies Limited — 4.1%
- Colgate Palmolive (India) Ltd. — 3.9%
Top sectors
- Telecom — 15.9%
- Pharma & Biotech — 12.3%
- Cash — 10.6%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | −0.5% | Q2 | #45 of 167 |
| 2025 | 2.3% | Q3 | #80 of 132 |
| 2024 | 24.7% | Q1 (Top) | #22 of 86 |